Kelley Cunningham

Kelley Cunningham serves as a Contract Specialist within the National CMOP Office of the Department of Veterans Affairs, where she plays a pivotal role in securing the domestic production and distribution of mission-critical pharmaceuticals, diagnostic substances, and medical consumables. Responsible for end-to-end acquisition execution, she manages complex contracts governed by FAR and VA-specific regulations, ensuring timely delivery of essential medications to veterans while supporting national supply chain resilience. Her acquisitions primarily involve manufacturing, packaging, and quality-assured distribution of controlled substances and in-vitro diagnostic products, requiring strict compliance with cGMP and FDA standards. Cunningham maintains consistent working relationships with a core group of specialized contractors, including All In Solutions LLC, Ansible Government Solutions LLC, and Innovation Associates, Inc., each of which provides niche expertise in pharmaceutical manufacturing, regulatory compliance, and logistics support. Her procurement approach emphasizes long-term vendor partnerships grounded in technical capability, quality assurance, and supply chain reliability, with a preference for contractors possessing proven experience in federal pharmaceutical production and sterile manufacturing environments. Her contracting patterns reflect a strong emphasis on open competition, with 93.9% of awards issued without set-asides, indicating a focus on mission-critical urgency and technical specificity over socioeconomic preferences. Nevertheless, she actively supports small business participation, with 5.7% of awards designated as total small business set-asides under FAR 19.5 and a small but intentional allocation to service-disabled veteran-owned small businesses. Cunningham’s procurement portfolio is heavily concentrated in NAICS 325412 (Pharmaceutical Preparation Manufacturing) and 325413 (In-Vitro Diagnostic Substance Manufacturing), reflecting deep expertise in the production of injectables, oral solids, and diagnostic reagents. She routinely manages acquisitions involving cold-chain logistics, stability testing, and controlled substance handling, demonstrating specialized knowledge in pharmaceutical supply chain integrity and federal regulatory compliance.